← Eichor
Study identifier: NCT04574089 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

Condition: Vaginitis  ·  Sponsor: Peking University Shenzhen Hospital

PhasePhase 3
Planned participants50
Who can joinFemale, 18 Years to 55 Years
Healthy volunteersNo

About this study

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Ping Liu, M.D.  ·  86755-83923333  ·  253783006@qq.com

Yiheng Liang, M.D.  ·  86755-83923333  ·  13510331823@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University Shenzhen HosptalShenzhen, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04574089